SKI Market

Indian Indices

Sensex

82,853.17 -821.75
( -0.98%)

Global Indices

Nasdaq

49,462.85 -679.56
(-1.36%)

Dow Jones

6,851.97 -110.50
(-1.59%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,413.72 -58.39
(-0.56%)

Forex

USD-INR

90.66 0.06
(0.07%)

EUR-INR

107.82 -0.02
(-0.02%)

GBP-INR

123.81 -0.01
(0.00%)

JPY-INR

0.59 0.01
(1.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

38.28

36093.9

EPS(TTM)

Face Value()

Div & Yield %

75.48

0.97

Back

datamatics global services ltd

Ashok Leyland Jan sales jump 27% to 21,920 units

Feb 01,2026

Ashok Leyland reported total sales of 21,920 units in month of January 2026 compared to 17,213 units in January 2025, recording a growth of 27%. Total sales include domestic sales of 20,079 units (up 31% YoY).

82,853.17 -821.75 ( -0.98%)

49,462.85 -679.56 (-1.36%)

6,851.97 -110.50 (-1.59%)

57,040.53 -599.31 (-1.04%)

10,413.72 -58.39 (-0.56%)

90.66 0.06 (0.07%)

107.82 -0.02 (-0.02%)

123.81 -0.01 (0.00%)

0.59 0.01 (1.13%)